RedHill Biopharma Ltd.RDHLNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank71
3Y CAGR-54.6%
5Y CAGR+5.0%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
-54.6%/yr
vs +115.1%/yr prior
5Y CAGR
+5.0%/yr
Recent deceleration
Acceleration
-169.7pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $8.04M | +23.2% |
| 2023 | $6.53M | -89.4% |
| 2022 | $61.80M | -27.9% |
| 2021 | $85.76M | +33.2% |
| 2020 | $64.36M | +923.0% |
| 2019 | $6.29M | -24.7% |
| 2018 | $8.36M | +108.6% |
| 2017 | $4.01M | +3867.3% |
| 2016 | $101000.00 | +3266.7% |
| 2015 | $3000.00 | - |